National HBPA to Breeders’ Cup: Keep Salix
Tom LaMarra
February 25, 2013
The organization voted to endorse the use of race-day furosemide during this year’s Breeders’ Cup races.
The organization voted to endorse the use of race-day furosemide during this year’s Breeders’ Cup races.
A tentative agenda includes consideration of new drug penalty structures and more.
Authorities are investigating two unrelated incidents occurring 15 minutes apart at The Meadows Racetrack.
Industry stakeholders met discuss creating uniform equine medication policy between states.
The FEI Tribunal delivered a record number of equine doping decisions during the first ten months of 2012.
The guild cited improved rider safety when they voted to support racehorse medication reform.
A review of violation records reveals that fewer Bute overages are occurring at a lower medication threshold.
The legislation calls for a ban on equine performance-enhancing drugs in horse racing in New York.
Both individuals violated rules involving prohibited or restricted drugs, medications, or substances.
Among the recommendations was a prohibition on corticosteroids joint injections within seven days of a race.
Officials are investigating how the two Standardbred horses might have been exposed to the drug.
Many leaders believe sweeping medication reform could become a reality in early 2013.
The changes are designed to prevent mistakes in Salix administration prior to races.
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
A panel discussed dealing with drug violators in horse racing and reported progress.
The winner of the Darley Prix Jean Romanet was disqualified after testing positive for an anti-inflammatory.
Stay on top of the most recent Horse Health news with
